Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Saved in:
| Title: | Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. |
|---|---|
| Authors: | Khaemba C; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Barry A; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden., Omondi WP; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Bota K; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Matendechero S; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Wandera C; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Siyoi F; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Kirui E; Ministry of Health -National Public Health Laboratory, Kenyatta National Hospital Grounds, 20750-00202 Nairobi, Kenya., Oluka M; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya., Nambwa P; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Gurumurthy P; Pharmacovigilance and Clinical Trials, Botswana Medicines Regulatory Authority, Gaborone 505155, Botswana., Njenga SM; Kenya Medical Research Institute (KEMRI), 54840-00200 Nairobi, Kenya., Guantai A; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Mar 15; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33804133 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Khaemba+C%22">Khaemba C</searchLink>; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Barry+A%22">Barry A</searchLink>; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Omondi+WP%22">Omondi WP</searchLink>; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Bota+K%22">Bota K</searchLink>; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Matendechero+S%22">Matendechero S</searchLink>; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Wandera+C%22">Wandera C</searchLink>; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Siyoi+F%22">Siyoi F</searchLink>; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kirui+E%22">Kirui E</searchLink>; Ministry of Health -National Public Health Laboratory, Kenyatta National Hospital Grounds, 20750-00202 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Oluka+M%22">Oluka M</searchLink>; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nambwa+P%22">Nambwa P</searchLink>; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Gurumurthy+P%22">Gurumurthy P</searchLink>; Pharmacovigilance and Clinical Trials, Botswana Medicines Regulatory Authority, Gaborone 505155, Botswana.<br /><searchLink fieldCode="AU" term="%22Njenga+SM%22">Njenga SM</searchLink>; Kenya Medical Research Institute (KEMRI), 54840-00200 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Guantai+A%22">Guantai A</searchLink>; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Aklillu+E%22">Aklillu E</searchLink>; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2021 Mar 15; Vol. 14 (3). <i>Date of Electronic Publication: </i>2021 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33804133 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph14030264 Languages: – Code: eng Text: English Titles: – TitleFull: Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Khaemba C – PersonEntity: Name: NameFull: Barry A – PersonEntity: Name: NameFull: Omondi WP – PersonEntity: Name: NameFull: Bota K – PersonEntity: Name: NameFull: Matendechero S – PersonEntity: Name: NameFull: Wandera C – PersonEntity: Name: NameFull: Siyoi F – PersonEntity: Name: NameFull: Kirui E – PersonEntity: Name: NameFull: Oluka M – PersonEntity: Name: NameFull: Nambwa P – PersonEntity: Name: NameFull: Gurumurthy P – PersonEntity: Name: NameFull: Njenga SM – PersonEntity: Name: NameFull: Guantai A – PersonEntity: Name: NameFull: Aklillu E IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2021 Mar 15 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 14 – Type: issue Value: 3 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |
